Hao Feng, MD
Experimental Surgical Research Division, Department of General, Visceral, Transplant and Vascular Surgery, University Hospital of LMU Munich, Germany
Dr. Feng finished his doctoral study in Ludwig-Maximilians-University of Munich studying the surgical oncology and immune modulation of colorectal liver metastases. Dr. Feng had his residency training in Nan-fang Hospital affiliated to Southern Medical University (the former First Military Medical University), and worked in Department of Education Administration at the meantime. He then worked in Rui-jin Hospital affiliated to Shanghai Jiao-tong University, School of Medicine and performed medical training as well as Ph.D. study in Ludwig-Maximilians-University of Munich. He is currently a visiting scholar and research scientist in Hospital of University of LMU Munich and Munich Red Cross Hospital in Germany, as well as a fellow scholar in SJTU national institute of hospital development in China.
His major research focuses involved the multidisciplinary treatment of gastrointestinal cancers, specifically, the combination of surgical approach, regeneration medicine, and immunotherapy for primary and metastatic gastrointestinal cancer. He has a major interest in the immune modulation of colorectal liver metastases, engineered liver models (microfluidic), colonic and pancreatic organoids as well as minimally invasive surgical approaches for colorectal cancer patients with elevated operative risk or early tumor stage. Dr. Feng is a member of American Association of Immunologists (AAI) and the author of many peer review publications in scientific journals including: Cancer Letter, Molecular cancer, Oncotarget, Surgery, International Journal of Colorectal Disease, European Surgical Research, etc.